Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chelsea Kotch

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Pediatrics in Review|October 2, 2020
A 7-month-old with Fever and Facial PalsyJennifer Fundora, Chelsea Kotch, Janet Serwint
Expert Review of Clinical Immunology|June 21, 2019
Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndromeChelsea Kotch, David Barrett, David T Teachey
Advances in Cancer Research|November 6, 2025
Pediatric-Type Diffuse Low Grade GliomaChelsea Kotch, Katherine Green, Michael J Fisher, et al.
Neuro-Oncology Advances|April 30, 2026
MEK inhibitors for neurofibromatosis type 1-associated central and peripheral nervous system tumorsChelsea Kotch, Peter de Blank, Jason Fangusaro, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|May 4, 2024
Low-grade glioma in children with neurofibromatosis type 1: surveillance, treatment indications, management, and future directionsChelsea Kotch, Peter de Blank, David H Gutmann, et al.
Pediatric Neurosurgery|February 6, 2023
Updates in the Management of Central and Peripheral Nervous System Tumors among Patients with Neurofibromatosis Type 1 and Neurofibromatosis Type 2Chelsea Kotch, Stephanie Nicole Brosius, Thomas De Raedt, et al.
Pediatrics|January 21, 2021
Conservative Management of Alloimmune Hemolysis and Cholestasis With Extreme Laboratory AbnormalitiesChelsea Kotch, David F Friedman, Benjamin J Wilkins, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 15, 2019
Expanding the MOG phenotype: Brainstem encephalitis with punctate and curvilinear enhancementSusan Matesanz, Chelsea Kotch, Christopher Perrone, et al.
Neuro-Oncology Advances|April 29, 2025
Location and extent of disease predicts outcome of neurofibromatosis type 1-related pediatric low-grade gliomasSneha M Chaturvedi, Arohi Saxena, Ahmad Hassan, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 24, 2022
Life-threatening altered mental status secondary to memantine in an adolescent undergoing cranial radiotherapy for medulloblastomaKristine N Kim, Yash B Shah, Colleen Croy, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Pediatrics in Review|October 2, 2020
A 7-month-old with Fever and Facial PalsyJennifer Fundora, Chelsea Kotch, Janet Serwint
Expert Review of Clinical Immunology|June 21, 2019
Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndromeChelsea Kotch, David Barrett, David T Teachey
Advances in Cancer Research|November 6, 2025
Pediatric-Type Diffuse Low Grade GliomaChelsea Kotch, Katherine Green, Michael J Fisher, et al.
Neuro-Oncology Advances|April 30, 2026
MEK inhibitors for neurofibromatosis type 1-associated central and peripheral nervous system tumorsChelsea Kotch, Peter de Blank, Jason Fangusaro, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|May 4, 2024
Low-grade glioma in children with neurofibromatosis type 1: surveillance, treatment indications, management, and future directionsChelsea Kotch, Peter de Blank, David H Gutmann, et al.
Pediatric Neurosurgery|February 6, 2023
Updates in the Management of Central and Peripheral Nervous System Tumors among Patients with Neurofibromatosis Type 1 and Neurofibromatosis Type 2Chelsea Kotch, Stephanie Nicole Brosius, Thomas De Raedt, et al.
Pediatrics|January 21, 2021
Conservative Management of Alloimmune Hemolysis and Cholestasis With Extreme Laboratory AbnormalitiesChelsea Kotch, David F Friedman, Benjamin J Wilkins, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 15, 2019
Expanding the MOG phenotype: Brainstem encephalitis with punctate and curvilinear enhancementSusan Matesanz, Chelsea Kotch, Christopher Perrone, et al.
Neuro-Oncology Advances|April 29, 2025
Location and extent of disease predicts outcome of neurofibromatosis type 1-related pediatric low-grade gliomasSneha M Chaturvedi, Arohi Saxena, Ahmad Hassan, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 24, 2022
Life-threatening altered mental status secondary to memantine in an adolescent undergoing cranial radiotherapy for medulloblastomaKristine N Kim, Yash B Shah, Colleen Croy, et al.
Pageof 2